BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 175 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,689,833 | -37.5% | 122,363 | +0.0% | 0.03% | -34.7% |
Q2 2023 | $2,703,095 | +19.7% | 122,312 | +17.8% | 0.05% | +14.0% |
Q1 2023 | $2,257,998 | -14.0% | 103,816 | -28.0% | 0.04% | -20.4% |
Q4 2022 | $2,625,332 | -16.7% | 144,249 | +4.2% | 0.05% | -19.4% |
Q3 2022 | $3,150,000 | +61.0% | 138,452 | -2.3% | 0.07% | +71.8% |
Q2 2022 | $1,957,000 | +153.8% | 141,698 | +318.0% | 0.04% | +200.0% |
Q1 2022 | $771,000 | +46.6% | 33,898 | +140.3% | 0.01% | +62.5% |
Q4 2021 | $526,000 | -11.3% | 14,105 | +0.7% | 0.01% | -11.1% |
Q3 2021 | $593,000 | -5.1% | 14,004 | -0.3% | 0.01% | 0.0% |
Q2 2021 | $625,000 | +30.8% | 14,043 | +5.8% | 0.01% | +12.5% |
Q1 2021 | $478,000 | -23.3% | 13,271 | -15.0% | 0.01% | -27.3% |
Q4 2020 | $623,000 | +17.1% | 15,607 | -15.1% | 0.01% | +10.0% |
Q3 2020 | $532,000 | +99.3% | 18,378 | +12.4% | 0.01% | +66.7% |
Q2 2020 | $267,000 | +75.7% | 16,346 | +2.2% | 0.01% | +50.0% |
Q1 2020 | $152,000 | – | 15,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,721,535 | $170,645,924 | 14.91% |
Gagnon Advisors, LLC | 360,758 | $7,972,751 | 5.34% |
Park West Asset Management LLC | 2,081,083 | $45,991,934 | 4.02% |
Meros Investment Management, LP | 324,479 | $7,170,986 | 3.56% |
GAGNON SECURITIES LLC | 637,576 | $14,090,429 | 2.93% |
Mesirow Financial Investment Management, Inc. | 16,947 | $374,529 | 1.59% |
Zweig-DiMenna Associates LLC | 256,000 | $5,657,600 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 1,561,443 | $34,507,882 | 0.68% |
PALISADE CAPITAL MANAGEMENT, LP | 1,134,352 | $25,069,179 | 0.67% |
Penbrook Management LLC | 41,500 | $917,150 | 0.66% |